GlassScriptPhysician profile
Dennis M Keyes
NPI 1649038159
$2,634.19
in general payments reported to CMS, 2019-2025
17 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,423 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,844 · Travel and Lodging: $745 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,844.00 |
| Travel and Lodging | $745.19 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,166.59 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Abbvie INC. | $374.45 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $283.98 | 2024-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $243.78 | 2024-2025 | Synchromedii, Inceptiv |
| Lundbeck LLC | $97.43 | 2024-2025 | Vyepti |
| Pfizer INC. | $88.21 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.43 | 2025 | Relistor |
| Axsome Therapeutics, INC. | $52.46 | 2025 | Sunosi |
| Merz Pharmaceuticals, LLC | $50.23 | 2025 | Xeomin |
| Mimedx Group, INC. | $34.39 | 2024 | |
| Globus Medical, INC. | $34.19 | 2025 | Senza |
| Spr Therapeutics, INC | $33.05 | 2025 | Sprint Pns System |
| Braeburn INC. | $20.48 | 2025 | Brixadi |
| Organogenesis INC. | $20.17 | 2025 | Cygnus Dual |
| Radius Health, INC. | $18.27 | 2024 | Tymlos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.63 | 2025 | |
| Ferring Pharmaceuticals INC. | $15.45 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.